Cited by 513COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchRespiratory Support and Mechanisms

The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Open access

Sun, Xinjuan, Wang, Tianyuan, Cai, Dayong, Hu, Zhiwei, Chen, Jin’an, Liao, Hui, Zhi, Liming, Wei, Hongxia, Zhang, Zhihong, Qiu, Yuying, Wang, Jing, Wang, Aiping·2020·Cytokine & Growth Factor Reviews

DOI 10.1016/j.cytogfr.2020.04.002PMC PMC7182527

Open this paper in CoChat — free account Open PDF

Abstract

Clinical intervention in patients with corona virus disease 2019 (COVID-19) has demonstrated a strong upregulation of cytokine production in patients who are critically ill with SARS-CoV2-induced pneumonia. In a retrospective study of 41 patients with COVID-19, most patients with SARS-CoV-2 infection developed mild symptoms, whereas some patients later developed aggravated disease symptoms, and eventually passed away because of multiple organ dysfunction syndrome (MODS), as a consequence of a severe cytokine storm. Guidelines for the diagnosis and treatment of SARS-CoV-2 infected pneumonia were first published January 30th, 2020; these guidelines recommended for the first time that cytokine monitoring should be applied in severely ill patients to reduce pneumonia related mortality. The cytokine storm observed in COVID-19 illness is also an important component of mortality in other viral diseases, including SARS, MERS and influenza. In view of the severe morbidity and mortality of COVID-19 pneumonia, we review the current understanding of treatment of human coronavirus infections from the perspective of a dysregulated cytokine and immune response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cytogfr.2020.04.002

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citation
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
Jin, Y., Cai, L., Cheng, Z., Cheng, H., Deng, T., Fan, Y., Fang, C., Huang, D., Huang, L., Huang, Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,306
Cytokine release syndrome
Shimabukuro‐Vornhagen, A., Gödel, P., Subklewe, M. S., Stemmler, H., Schlößer, H., Schlaak, M. S., Kochanek, M., Böll, B., & von Bergwelt‐Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,712
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,428

Show all 36 references

Research works printed but not linked: 3

Tian, 2020, Pulmonary pathology of early phase SARS-COV-2 pneumonia, Preprints
Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 · DOI · Paper page
Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 10.1016/S2213-2600(20)30076-X · DOI · Paper page

Sorted by citations

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Machhi, J., Herskovitz, J., Senan, A. M., Dutta, D., Nath, B., Oleynikov, M. D., Blomberg, W. R., Meigs, D. D., Hasan, M., Patel, M., et al. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09944-5 · Cited by 642
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Nile, S. H., Nile, A. S., Qiu, J., Li, L., Jia, X., & Kai, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.002 · Cited by 452
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Villapol, S. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.004 · Cited by 341
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Afrin, L. B., Weinstock, L. B., & Molderings, G. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.016 · Cited by 319
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A. C., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 302
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Ramasamy, S., & Subbian, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00299-20 · Cited by 307
Pharmaco-Immunomodulatory Therapy in COVID-19
Rizk, J. G., Kalantar‐Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 298
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
Ng, W. H., Tipih, T., Aminake, M. N., Vermeulen, J., Goedhals, D., Sempa, J. B., Burt, F. J., Taylor, A., & Mahalingam, S. (2021) · mBio · doi:10.1128/mbio.03647-20 · Cited by 296
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Rabaan, A. A., Al-Ahmed, S. H., Muhammad, J., Khan, A., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Al‐Omari, A., Dhawan, M. K., et al. (2021) · Vaccines · doi:10.3390/vaccines9050436 · Cited by 262
How can nanotechnology help to combat COVID-19? Opportunities and urgent need
Campos, E. V. R., Pereira, A. D. E. S., de Oliveira, J. L., Carvalho, L. B., Guilger‐Casagrande, M., de Lima, R., & Fraceto, L. F. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00685-4 · Cited by 234
Cytokine profile and disease severity in patients with COVID-19
Ghazavi, A., Ganji, A., Keshavarzian, N., Rabiemajd, S., & Mosayebi, G. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155323 · Cited by 211
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Choudhary, S., Sharma, K., & Silakari, O. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104673 · Cited by 212
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Cantini, F., Niccoli, L., Nannini, C., Matarrese, D., Natale, M. E. D., Lotti, P., Aquilini, D., Landini, G., Cimolato, B., Pietro, M. A. D., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.052 · Cited by 174
COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
Sorokin, A. V., Karathanasis, S. K., Yang, Z., Freeman, L. A., Kotani, K., & Remaley, A. T. (2020) · The FASEB Journal · doi:10.1096/fj.202001451 · Cited by 170
Addressing male sexual and reproductive health in the wake of COVID-19 outbreak
Sansone, A., Mollaioli, D., Ciocca, G., Limoncin, E., Colonnello, E., Vena, W., & Jannini, E. A. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01350-1 · Cited by 170
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
Shao, Z., Feng, Y., Zhong, L., Xie, Q., Lei, M., Liu, Z., Wang, C., Ji, J., Liu, H., Gu, Z., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1192 · Cited by 161
Self-citation
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
Daamen, A. R., Bachali, P., Owen, K. A., Kingsmore, K. M., Hubbard, E. L., Labonte, A. C., Robl, R. D., Shrotri, S., Grammer, A. C., & Lipsky, P. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86002-x · Cited by 151
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 148
Impact of obesity on COVID-19 patients
Yu, W., Rohli, K. E., Yang, S., & Jia, P. (2020) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2020.107817 · Cited by 101
Neurological complications and infection mechanism of SARS-CoV-2
Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 140
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Lee, W., Ahn, J. H., Park, H. H., Kim, H. N., Kim, H., Yoo, Y., Shin, H., Hong, K. S., Jang, J. G., Park, C. G., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00292-7 · Cited by 141
COVID‐19 coagulopathy: An in‐depth analysis of the coagulation system
Martín‐Rojas, R. M., Pérez‐Rus, G., Delgado‐Pinos, V. E., Domingo‐González, A., Regalado‐Artamendi, I., Alba‐Urdiales, N., Rodríguez, P. D., Monsalvo, S., Rodríguez‐Macías, G., Ballesteros, M., et al. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13501 · Cited by 135
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
Vahedifard, F., & Chakravarthy, K. V. (2021) · Emergent Materials · doi:10.1007/s42247-021-00168-8 · Cited by 129
Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens
Mahajan, S., Choudhary, S., Kumar, P., & Tomar, S. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116356 · Cited by 127
Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic
Ambardar, S., Hightower, S. L., Huprikar, N., Chung, K. K., SINGHAL, A. L., & Collen, J. F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112452 · Cited by 120
Coronavirus Disease 2019 (COVID-19) and Nutritional Status: The Missing Link?
Silvério, R., Gonçalves, D. C., Andrade, M. F., & Seelaender, M. C. L. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa125 · Cited by 120
A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance
Kumar, M., Mazumder, P., Mohapatra, S., Thakur, A. K., Dhangar, K., Taki, K., Mukherjee, S., Patel, A. K., Bhattacharya, P., Mohapatra, P. K., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124043 · Cited by 109
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Attiq, A., Yao, L. J., Afzal, S., & Khan, M. A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108255 · Cited by 111
Revisiting Platelets and Toll-Like Receptors (TLRs): At the Interface of Vascular Immunity and Thrombosis
Hally, K. E., Fauteux‐Daniel, S., Hamzeh‐Cognasse, H., Larsen, P., & Cognasse, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176150 · Cited by 105
Gendered effects on inflammation reaction and outcome of COVID‐19 patients in Wuhan
Qin, L., Li, X., Shi, J. C., Yu, M., Wang, K., Tao, Y., Zhou, Y., Zhou, M., Xu, S., Wu, B., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26137 · Cited by 103
SARS‐CoV‐2‐specific virulence factors in COVID‐19
Kumar, A., Prasoon, P., Kumari, C., Pareek, V., Faiq, M. A., Narayan, R. K., Kulandhasamy, M., & Kant, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26615 · Cited by 112
Systemic lupus erythematosus manifestation following COVID-19: a case report
Zamani, B., Taba, S. M. M., & Shayestehpour, M. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-020-02582-8 · Cited by 101
The cytokine storm of COVID-19: a spotlight on prevention and protection
Pearce, L., Davidson, S. M., & Yellon, D. M. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1783243 · Cited by 99
Nanocarrier vaccines for SARS-CoV-2
Machhi, J., Shahjin, F., Das, S., Patel, M., Abdelmoaty, M. M., Cohen, J. D., Singh, P. A., Baldi, A., Bajwa, N., Kumar, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.002 · Cited by 100
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
Koshak, A. E., Koshak, A. E., Mobeireek, A. F., Badawi, M., Wali, S., Malibary, H. M., Atwah, A. F., Alhamdan, M. M., Almalki, R. A., & Madani, T. A. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102769 · Cited by 97
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 97
Association between cytokine profiles and lung injury in COVID-19 pneumonia
Chen, L., Zhang, Z., Wei, X., Cai, Y., Yao, W.-Z., Wang, M., Huang, Q.-F., & Zhang, X. (2020) · Respiratory Research · doi:10.1186/s12931-020-01465-2 · Cited by 92
Self-citation
Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset
Azoulay, É., Fartoukh, M. S., Darmon, M., Géri, G., Voiriot, G., Dupont, T., Zafrani, L., Girodias, L., Labbé, V., Dres, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06202-3 · Cited by 91
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Brandão, S. C. S., Ramos, J. D. O. X., Dompieri, L. T., Godoi, E. T. A. M., de Figueiredo, J. L., SARINHO, E. S. C., Chelvanambi, S., & Aikawa, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.09.002 · Cited by 93
Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh
Akter, F., Mannan, A., Mehedi, H. M. H., Rob, M. A., Ahmed, S., Salauddin, A., Hossain, M. S., & Hasan, M. M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.016 · Cited by 90
Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19Preprint
Varadhachary, A., Chatterjee, D. K., Garza, J. T., Garr, R. P., Foley, C., Letkeman, A., Dean, J., Haug, D., Breeze, J., Traylor, R., et al. (2020) · medRxiv · doi:10.1101/2020.08.07.20170258 · Cited by 89
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
Rowaiye, A. B., Okpalefe, O. A., Onuh, O. A., Ogidigo, J. O., Oladipo, O. H., Ogu, A. C., Oli, A. N., Olofinsae, S. A., Onyekwere, O., Abubakar, A. R., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s301784 · Cited by 87
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis
Liu, Y., Pan, Y., Yin, Y., Chen, W., & Li, X. (2021) · Virology Journal · doi:10.1186/s12985-021-01604-1 · Cited by 94
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment
Jayaramayya, K., Iyer, M., Subramaniam, M. D., Raj, N., Dayem, A. A., Lim, K. M., Kim, S., An, J., Lee, Y., Choi, Y., et al. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.8.121 · Cited by 82
Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up
Rossi, N. D., Scarpazza, C., Filippini, C., Cordioli, C., Rasia, S., Mancinelli, C. R., Rizzoni, D., Romanelli, G., Cossi, S., Vettoretto, N., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100459 · Cited by 80
Basophils and Mast Cells in COVID-19 Pathogenesis
Murdaca, G., Gioacchino, M. D., Greco, M., Borro, M., Paladin, F., Petrarca, C., & Gangemi, S. (2021) · Cells · doi:10.3390/cells10102754 · Cited by 83
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
Menzella, F., Fontana, M. S., Salvarani, C., Massari, M., Ruggiero, P., Scelfo, C., Barbieri, C., Castagnetti, C., Catellani, C., Gibellini, G., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03306-6 · Cited by 77
Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α
Frisoni, P., Neri, M., D’Errico, S., Alfieri, L., Bonuccelli, D., Cingolani, M., Paolo, M. D., Gaudio, R. M., Lestani, M., Marti, M., et al. (2021) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-021-00414-9 · Cited by 85
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
Qudus, M. S., Tian, M., Sirajuddin, S., Liu, S., Afaq, U., Wali, M., Liu, J., Pan, P., Luo, Z., Zhang, Q., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28751 · Cited by 84
Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis
Xiang, H., Cheng, X., Li, Y., Luo, W.-W., Zhang, Q., & Wen-xing, P. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107732 · Cited by 74
Diabetes, Drug Treatment and Mortality in COVID-19: A Multinational Retrospective Cohort Study
Nyland, J. E., Raja-Khan, N. T., Bettermann, K., Haouzi, P. A., LESLIE, D. L., Kraschnewski, J. L., Parent, L. J., & Grigson, P. S. (2020) · Diabetes · doi:10.2337/db21-0385 · Cited by 74
Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome—with a preliminary reference to SARS-CoV-2 pneumonia
Land, W. G. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00140-w · Cited by 77
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
Siriwattananon, K., Manopwisedjaroen, S., Shanmugaraj, B., Rattanapisit, K., Phumiamorn, S., Sapsutthipas, S., Trisiriwanich, S., Prompetchara, E., Ketloy, C., Buranapraditkun, S., et al. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.682953 · Cited by 68
Role of NLR, PLR, ELR and CLR in differentiating COVID‐19 patients with and without pneumonia
Çakırca, T. D., Torun, A. N., Çakırca, G., & Portakal, R. D. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14781 · Cited by 67
Precise regulation of inflammation and immunosuppressive microenvironment for amplified photothermal/immunotherapy against tumour recurrence and metastasis
Wang, Y., Xu, C., Meng, M., Lin, L., Hu, Y., Hao, K., Shu, S., Zhang, S., Wu, J., Liu, F., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101266 · Cited by 64
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Yin, J., Li, C., Ye, C., Ruan, Z., Liang, Y., Li, Y., Wu, J., & Luo, Z. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.01.026 · Cited by 66
The Spectrum of Gastrointestinal Symptoms in Patients With Coronavirus Disease-19: Predictors, Relationship With Disease Severity, and Outcome
Ghoshal, U. C., Ghoshal, U., Mathur, A., Singh, R. K., Nath, A., Garg, A., Singh, D., Singh, S. K., Singh, J., Pandey, A., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000259 · Cited by 62
Alterations of Lipid Profile in COVID-19: A Narrative Review
Rezaei, A., Neshat, S., & Heshmat‐Ghahdarijani, K. (2021) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2021.100907 · Cited by 63
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Hasankhani, A., Bahrami, A., Sheybani, N., Aria, B., Hemati, B., Fatehi, F., Farahani, H. G. M., Javanmard, G., Rezaee, M., Kastelic, J. P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.789317 · Cited by 62
Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality
Moradian, N., Gouravani, M., Salehi, M. A., Heidari, A., Shafeghat, M., Hamblin, M. R., & Rezaei, N. (2020) · European Cytokine Network · doi:10.1684/ecn.2020.0451 · Cited by 60
Autoimmunity and COVID-19 – The microbiotal connection
Katz-Agranov, N. S., & Zandman‐Goddard, G. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102865 · Cited by 64
Tip of the iceberg: erectile dysfunction and COVID-19
Kaynar, M., Quinta-Gomes, A. L., Sokolakis, I., & Gül, M. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-022-00540-0 · Cited by 60
Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects
Chen, X., Shan, Y., Wen, Y., Sun, J. T., & Du, H. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.020 · Cited by 59
Fighting against the second wave of COVID-19: Can honeybee products help protect against the pandemic?
Naggar, Y. A., Giesy, J. P., Abdel‐Daim, M. M., Ansari, M. J., Al-Kahtani, S. N., & Yahya, G. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.12.031 · Cited by 66
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
Kumar, D., Jahan, S., Khan, A., Siddiqui, A. J., Redhu, N. S., Wahajuddin, M., Khan, J., Banawas, S., Alshehri, B., & Alaidarous, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02318-9 · Cited by 60
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
Port, A., Shaw, J. V., Klopp‐Schulze, L., Bytyqi, A. H., Vetter, C., Hussey, E. K., Mammasse, N., Ona, V. O., Bachmann, A., Strugala, D., et al. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.842 · Cited by 58
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II
Fathi-Kazerooni, M., Ghazi, S. F., Darzi, M., Makarem, J., Nasiri, R., Salahshour, F., Manshadi, S. A. D., & Kazemnejad, S. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02771-w · Cited by 57
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
Ali, S., Uddin, S. M., Shalim, E., Sayeed, M. A., Anjum, F., Saleem, F., Muhaymin, S. M., Ali, A., Ali, M. R., Ahmed, I., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100926 · Cited by 60
NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
Gillot, C., Favresse, J., Mullier, F., Lecompte, T., Dogné, J., & Douxfils, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708302 · Cited by 57
Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study)
Mareev, V. Y., Orlova, Y. A., Павликова, Е. П., Мацкеплишвили, С. Т., Krasnova, T. N., Малахов, П. С., Samokhodskaya, L. M., Mershina, E. A., Sinitsyn, V. E., Mareev, Y. V., et al. (2020) · Kardiologiia · doi:10.18087/cardio.2020.6.n1226 · Cited by 54
Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
Siriwattananon, K., Manopwisedjaroen, S., Kanjanasirirat, P., Purwono, P. B., Rattanapisit, K., Shanmugaraj, B., Smith, D. R., Borwornpinyo, S., Thitithanyanont, A., & Phoolcharoen, W. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2020.604663 · Cited by 55
Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2
Masih, A., Agnihotri, A. K., Srivastava, J. K., Pandey, N., Bhat, H. R., & Singh, U. P. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22656 · Cited by 54
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
Longo, M., Caruso, P., Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01090-9 · Cited by 54
Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection
Kaneko, N., Satta, S., Komuro, Y., Muthukrishnan, S. D., Kakarla, V., Guo, L., An, J., Elahi, F. M., Kornblum, H. I., Liebeskind, D. S., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.032764 · Cited by 53
Corticosteroids for COVID-19: worth it or not?
Akter, F., Araf, Y., & Hosen, M. J. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06793-0 · Cited by 53
Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements
Rao, K. S. J., Vaddi, S., Senthilkumar, R., Preethy, S., Katoh, S., Ikewaki, N., & Abraham, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01548 · Cited by 52
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection
Hashemi, S. M. A., Thijssen, M., Hosseini, S. Y., Tabarraei, A., Pourkarim, M. R., & Sarvari, J. (2021) · Archives of Virology · doi:10.1007/s00705-021-05070-6 · Cited by 56
Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
Sadeghian, I., Heidari, R., Sadeghian, S., Raee, M. J., & Negahdaripour, M. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106094 · Cited by 56
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Kudriavtsev, A. V., Vakhrusheva, A., Novoseletsky, V. N., Bozdaganyan, M. E., Шайтан, К. В., Kirpichnikov, M. P., & Sokolova, O. S. (2022) · Viruses · doi:10.3390/v14081603 · Cited by 52
Lung fibrosis: Post-COVID-19 complications and evidences
Hirawat, R., Jain, N., Saifi, M. A., Rachamalla, M., & Godugu, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109418 · Cited by 54
Long Noncoding RNAs as Emerging Regulators of COVID-19
Yang, Q., Fang, L., Wang, Y., Min De, Z. E. N. G., & Luo, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700184 · Cited by 51
Pediatric adenovirus pneumonia: clinical practice and current treatment
Zhang, J., Zhu, Y., Zhou, Y., Gao, F., Qiu, X., Li, J., Yuan, H., Jin, W., & Lin, W. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1207568 · Cited by 50
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Zheng, J., Miao, J., Guo, R., Guo, J., Fan, Z., Kong, X., Gao, R., & Yang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.931061 · Cited by 49
Bioengineered Neutrophil Extinguisher Targets Cascade Immune Pathways of Macrophages for Alleviating Cytokine Storm in Pneumonia.
Zhou, A.-W., Chen, K.-R., Gao, Y., Zhou, X., Tian, Z., Chen, W., Xu, Y.-R., Chen, Z., & Ning, X.-H. (2023) · ACS Nano · doi:10.1021/acsnano.3c00227 · Cited by 44
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
Sarohan, A. R., Kızıl, M., İnkaya, A. Ç., Mahmud, S. O., Akram, M., & Çen, O. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110121 · Cited by 44
SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure
Stasi, A., Castellano, G., Ranieri, E., Infante, B., Stallone, G., Gesualdo, L., & Netti, G. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124057 · Cited by 43
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
Peñaloza, H. F., Lee, J. S., & Ray, P. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009850 · Cited by 44
The Coronavirus pandemic – 2022: Viruses, variants & vaccines
Alexandridi, M., Mazej, J., Palermo, E., & Hiscott, J. B. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.02.002 · Cited by 44
Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection
Chaudhary, R., Meher, A., Krishnamoorthy, P., & Kumar, H. (2023) · Current Research in Immunology · doi:10.1016/j.crimmu.2023.100062 · Cited by 42
Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
Wielgat, P., Rogowski, K., Godlewska, K., & Car, H. (2020) · Cells · doi:10.3390/cells9091963 · Cited by 43
Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review
Tomerak, S., Khan, S., Almasri, M., Hussein, R., Abdelati, A. A., Aly, A. M., Salameh, M. A., Aldien, A. S., Naveed, H., Elshazly, M. B., et al. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13097 · Cited by 43
Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality
EL-Gendy, A. O., Saeed, H., Ali, A. M. A., Zawbaa, H. M., Gomaa, D., Harb, H. S., Madney, Y. M., Osama, H., Abdelrahman, M. A., & Abdelrahim, M. E. A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.083 · Cited by 42
Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines
Salahshoori, I., Mobaraki-Asl, N., Seyfaee, A., Nasirabad, N. M., Dehghan, Z., Faraji, M., Ganjkhani, M., Babapoor, A., Shadmehr, S., & Hamrang, A. (2021) · Biologics · doi:10.3390/biologics1010002 · Cited by 46
Commonalities Between COVID-19 and Radiation Injury
Rios, C. I., Cassatt, D. R., Hollingsworth, B. A., Satyamitra, M. M., Tadesse, Y., Taliaferro, L. P., Winters, T. A., & DiCarlo, A. L. (2020) · Radiation Research · doi:10.1667/rade-20-00188.1 · Cited by 43
Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis
Limanaqi, F., Busceti, C. L., Biagioni, F., Lazzeri, G., Forte, M., Schiavon, S., Sciarretta, S., Frati, G., & Fornai, F. (2020) · Antioxidants · doi:10.3390/antiox9111105 · Cited by 41
A Multifunctional Peptide From Bacillus Fermented Soybean for Effective Inhibition of SARS-CoV-2 S1 Receptor Binding Domain and Modulation of Toll Like Receptor 4: A Molecular Docking Study
Padhi, S., Sanjukta, S., Chourasia, R., Labala, R. K., Singh, S. P., & Rai, A. K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.636647 · Cited by 41
Targeting zinc metalloenzymes in coronavirus disease 2019
Doboszewska, U., Właź, P., Nowak, G., & Młyniec, K. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15199 · Cited by 36
PMMA-Based Continuous Hemofiltration Modulated Complement Activation and Renal Dysfunction in LPS-Induced Acute Kidney Injury
Stasi, A., Franzin, R., Divella, C., Sallustio, F., Curci, C., Picerno, A., Pontrelli, P., Staffieri, F., Lacitignola, L., Crovace, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.605212 · Cited by 38
Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
Revercomb, L., Hanmandlu, A., Wareing, N. E., Akkanti, B. H., & Karmouty‐Quintana, H. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.624093 · Cited by 41

Authors: Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., Wang, J., & Wang, A.
Affiliations: Chinese People's Liberation Army (CN)
Nanjing University of Chinese Medicine (CN)
Jiangsu Province Hospital (CN)
Nanjing Drum Tower Hospital (CN)
Corresponding author: Wang, Jing
Wang, Aiping
ORCID: Wang, Tianyuan
Wei, Hongxia
Zhang, Zhihong
Wang, Jing
Wang, Aiping
Venue: Cytokine & Growth Factor Reviews
Publisher: Elsevier BV
Published: 2020-06
Volume: 53
Pages: 38-42
ISSN: 1359-6101 (ISSN-L)
DOI: 10.1016/j.cytogfr.2020.04.002
PMC: PMC7182527
OpenAlex: W3019663170
Cited by: 513
References: 36
Citations by year: 2026: 9 · 2025: 23 · 2024: 32 · 2023: 77 · 2022: 110 · 2021: 160 · 2020: 102
FWCI: 5.30
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Cytokine & Growth Factor Reviews (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
Keywords: cytokine storm, COVID-19 pandemic, SARS-CoV-2, COVID-19 pneumonia, cytokine monitoring, multiple organ failure, immune dysregulation, cytokine production, mortality, SARS, MERS, influenza, antiviral therapy
MeSH terms: Betacoronavirus, Continuous Renal Replacement Therapy, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Adrenal Cortex Hormones, Antibodies, Monoclonal, Female, Humans, Male, Multiple Organ Failure, Pneumonia, Viral, Polyethylene Glycols, Recombinant Proteins, Retrospective Studies, Cytokines, Interferon-alpha, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks